Insperity (NSP) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
8 Jul, 2026Executive summary
Q2 2024 delivered strong financial results, with adjusted EPS up 34% to $0.86 and adjusted EBITDA up 29% to $66 million, both exceeding guidance, despite a 1% year-over-year decline in average paid worksite employees due to lower net hiring and SMB market challenges.
Client retention remained high at 99% in Q2 2024 and Q2 2023.
Sales and marketing initiatives generated solid new and previously booked business, though paid worksite employee growth lagged expectations.
Strategic partnership with Workday advanced, with significant investments and operational milestones achieved.
Year-to-date, net income fell 9% to $97 million and diluted EPS decreased 8% to $2.56, while adjusted EBITDA rose 2% to $208 million.
Financial highlights
Q2 2024 revenues increased 1% year-over-year to $1.61 billion; gross profit rose 16% to $260 million, driven by strong pricing and lower benefit costs.
Adjusted EPS for Q2 2024 was $0.86, up 34% year-over-year and above guidance; adjusted EBITDA reached $66 million, up 29%.
Operating expenses rose 13% year-over-year, reflecting investments in the Workday partnership and growth initiatives.
Effective tax rate for Q2 was 28%, up from 25% in Q2 2023.
Adjusted cash at June 30, 2024 was $211 million, up from $171 million at year-end 2023, with $280 million available under the credit facility.
Outlook and guidance
Full-year 2024 adjusted EPS guidance is $3.33–$3.88, with the midpoint above prior guidance, but outlook revised downward due to macroeconomic and political uncertainty.
Adjusted EBITDA for 2024 expected at $261–$290 million.
Average paid worksite employees for 2024 revised to 307,400–310,600, a 0.5%–1.5% decline year-over-year; Q3 2024 guidance anticipates a 2.5%–1.5% year-over-year decrease in average WSEEs paid.
Q3 2024 adjusted EPS guidance: $0.21–$0.45; adjusted EBITDA: $32–$45 million, both reflecting significant year-over-year declines.
Management expects liquidity needs to be met for the remainder of 2024.
Latest events from Insperity
- Q2 net income jumped 180% on 2% revenue growth, with margin recovery driving profitability.NSP
Q2 2026 - Margin recovery and cost controls offset lower worksite employee growth and pressured profits.NSP
Q1 2026 - Proxy seeks approval for director elections, pay, equity plan amendment, and auditor ratification.NSP
Proxy filing - 2026 guidance targets margin recovery and growth, led by HRScale and cost controls.NSP
Q4 2025 - Annual Meeting to vote on directors, pay, incentive plan amendment, and auditor ratification.NSP
Proxy Filing - Q3 revenue up 4% but net loss and EBITDA fell on higher costs; 2026 recovery expected.NSP
Q3 2025 - Q3 net income and EPS dropped sharply, with full-year adjusted EPS guided at $3.42–$3.66.NSP
Q3 2024 - Higher healthcare costs and economic uncertainty drove lower Q1 earnings despite revenue growth.NSP
Q1 2025 - Solid Q4 results, resilient profitability, and Workday partnership set stage for 2025 growth.NSP
Q4 2024